<?xml version='1.0' encoding='UTF-8'?>
<frameset>
  <predicate lemma="acetylate">
    <roleset id="acetylate.01" name="introduce an acetyl group into a compound">
      <aliases>
        <alias pos="v">acetylate</alias>
        <alias pos="n">acetylation</alias>
      </aliases>
      <roles>
        <role descr="agent of acetylation (e.g. scientist)" f="PAG" n="0"/>
        <role descr="thing acetylated (material/source)" f="PPT" n="1"/>
        <role descr="instrument" f="MNR" n="2"/>
        <role descr="product of acetylation" f="PRD" n="3"/>
      </roles>
      <usagenotes>
        <usage resource="PropBank" version="3.0" inuse="+"/>
        <usage resource="AMR" version="2019" inuse="+"/>
      </usagenotes>
      <lexlinks/>
      <example src="" name="acetylate-v: patient and product of the reaction">
        <text> The new NH2-terminal glycine is acetylated from acetyl-CoA when the polypeptide is 44 residues long.</text>
        <rel relloc="6">acetylated</rel>
        <arg f="" n="3" start="1" end="4">The new NH2-terminal glycine</arg>
        <arg f="" n="1" start="7" end="8">from acetyl-CoA</arg>
      </example>
      <example src="" name="acetylate-v: agent and instrument">
        <text>We acetylated recombinant OGG1 with p300 (HAT domain) and confirmed acetylation by Western analysis with AcOGG1 antibody (Fig. 6A, lane 2).</text>
        <rel relloc="1">acetylated</rel>
        <arg f="" n="0" start="0" end="0">We</arg>
        <arg f="" n="1" start="2" end="3">recombinant OGG1</arg>
        <arg f="" n="2" start="4" end="7">with p300 (HAT domain)</arg>
      </example>
      <example src="" name="acetylation-n">
        <text>Acetylation of histones alters accessibility of chromatin</text>
        <rel relloc="0">Acetylation</rel>
        <arg f="" n="1" start="1" end="2">of histones</arg>
      </example>
      <note>ACETYLATE-V NOTES: Created for Bio-AMR annotations.</note>
    </roleset>
  </predicate>
</frameset>
